Global Myasthenia Gravis Diagnostic Reagents and Equipment Production, Demand and Key Producers, 2022-2028
At present, serological antibodies and electrophysiological examinations provide the main basis for the diagnosis of MG, including single-fiber electromyography (the highest sensitivity, about 99%), serum antibody detection (high specificity, ocular muscle type sensitivity is about 50%, systemic type 85%), repetitive electrical stimulation (lower sensitivity when detecting proximal muscles, about 76%). AchEI can be used to help support the diagnosis of MG, and based on its clinical response, it can indicate a positive response to long-term treatment, but its current application is limited due to objectivity defects and false positives. Edrophonium testing can cause life-threatening complications that may require urgent resuscitation and is currently/banned in Italy and several other countries. In contrast, the neostigmine trial was more safe and reliable.
This report studies the global Myasthenia Gravis Diagnostic Reagents and Equipment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Myasthenia Gravis Diagnostic Reagents and Equipment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Myasthenia Gravis Diagnostic Reagents and Equipment that contribute to its increasing demand across many markets.
The global Myasthenia Gravis Diagnostic Reagents and Equipment market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Myasthenia Gravis Diagnostic Reagents and Equipment total production and demand, 2017-2028, (K Units)
Global Myasthenia Gravis Diagnostic Reagents and Equipment total production value, 2017-2028, (USD Million)
Global Myasthenia Gravis Diagnostic Reagents and Equipment production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Myasthenia Gravis Diagnostic Reagents and Equipment consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Myasthenia Gravis Diagnostic Reagents and Equipment domestic production, consumption, key domestic manufacturers and share
Global Myasthenia Gravis Diagnostic Reagents and Equipment production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Myasthenia Gravis Diagnostic Reagents and Equipment production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Myasthenia Gravis Diagnostic Reagents and Equipment production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Myasthenia Gravis Diagnostic Reagents and Equipment market based on the following parameters – headquarters, production locations, products portfolio, Myasthenia Gravis Diagnostic Reagents and Equipment revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Myasthenia Gravis Diagnostic Reagents and Equipment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Myasthenia Gravis Diagnostic Reagents and Equipment Market, By Region:
1. How big is the global Myasthenia Gravis Diagnostic Reagents and Equipment market?
2. What is the demand of the global Myasthenia Gravis Diagnostic Reagents and Equipment market?
3. What is the year over year growth of the global Myasthenia Gravis Diagnostic Reagents and Equipment market?
4. What is the production and production value of the global Myasthenia Gravis Diagnostic Reagents and Equipment market?
5. Who are the key producers in the global Myasthenia Gravis Diagnostic Reagents and Equipment market?
6. What are the growth factors driving the market demand?
This report studies the global Myasthenia Gravis Diagnostic Reagents and Equipment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Myasthenia Gravis Diagnostic Reagents and Equipment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Myasthenia Gravis Diagnostic Reagents and Equipment that contribute to its increasing demand across many markets.
The global Myasthenia Gravis Diagnostic Reagents and Equipment market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Myasthenia Gravis Diagnostic Reagents and Equipment total production and demand, 2017-2028, (K Units)
Global Myasthenia Gravis Diagnostic Reagents and Equipment total production value, 2017-2028, (USD Million)
Global Myasthenia Gravis Diagnostic Reagents and Equipment production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Myasthenia Gravis Diagnostic Reagents and Equipment consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Myasthenia Gravis Diagnostic Reagents and Equipment domestic production, consumption, key domestic manufacturers and share
Global Myasthenia Gravis Diagnostic Reagents and Equipment production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Myasthenia Gravis Diagnostic Reagents and Equipment production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Myasthenia Gravis Diagnostic Reagents and Equipment production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Myasthenia Gravis Diagnostic Reagents and Equipment market based on the following parameters – headquarters, production locations, products portfolio, Myasthenia Gravis Diagnostic Reagents and Equipment revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Myasthenia Gravis Diagnostic Reagents and Equipment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Myasthenia Gravis Diagnostic Reagents and Equipment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Detection reagent
- EMG equipment
- Hospital
- Specialist Outpatient Clinic
- Research Institutions
- Other
- Argenx SE
- American Regent
- Abcam
- Sigma-Aldrich
- BioAssay Systems
- Attogene
- Cambridge Bioscience
- Invitrogen
- Assay Genie
- Neuro Medical Equipment, Inc.
- Medtronic
- Nihon Kohden
- Natus Medical
- Compumedics
- Philips Healthcare
- Micromed S.p.A.
- Wuhan Huamei Biological Engineering Co., Ltd.
1. How big is the global Myasthenia Gravis Diagnostic Reagents and Equipment market?
2. What is the demand of the global Myasthenia Gravis Diagnostic Reagents and Equipment market?
3. What is the year over year growth of the global Myasthenia Gravis Diagnostic Reagents and Equipment market?
4. What is the production and production value of the global Myasthenia Gravis Diagnostic Reagents and Equipment market?
5. Who are the key producers in the global Myasthenia Gravis Diagnostic Reagents and Equipment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Myasthenia Gravis Diagnostic Reagents and Equipment Introduction
1.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Supply & Forecast
1.2.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value (2017 & 2021 & 2028)
1.2.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028)
1.2.3 World Myasthenia Gravis Diagnostic Reagents and Equipment Pricing Trends (2017-2028)
1.3 World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Region
1.3.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Region (2017-2028)
1.3.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Region (2017-2028)
1.3.3 World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Region (2017-2028)
1.3.4 North America Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028)
1.3.5 Europe Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028)
1.3.6 China Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028)
1.3.7 Japan Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Myasthenia Gravis Diagnostic Reagents and Equipment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Myasthenia Gravis Diagnostic Reagents and Equipment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Demand (2017-2028)
2.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption by Region
2.2.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption by Region (2017-2022)
2.2.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Forecast by Region (2023-2028)
2.3 United States Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
2.4 China Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
2.5 Europe Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
2.6 Japan Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
2.7 South Korea Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
2.8 ASEAN Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
2.9 India Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
3 WORLD MYASTHENIA GRAVIS DIAGNOSTIC REAGENTS AND EQUIPMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Manufacturer (2017-2022)
3.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Manufacturer (2017-2022)
3.3 World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Manufacturer (2017-2022)
3.4 Myasthenia Gravis Diagnostic Reagents and Equipment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Myasthenia Gravis Diagnostic Reagents and Equipment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Myasthenia Gravis Diagnostic Reagents and Equipment in 2021
3.5.3 Global Concentration Ratios (CR8) for Myasthenia Gravis Diagnostic Reagents and Equipment in 2021
3.6 Myasthenia Gravis Diagnostic Reagents and Equipment Market: Overall Company Footprint Analysis
3.6.1 Myasthenia Gravis Diagnostic Reagents and Equipment Market: Region Footprint
3.6.2 Myasthenia Gravis Diagnostic Reagents and Equipment Market: Company Product Type Footprint
3.6.3 Myasthenia Gravis Diagnostic Reagents and Equipment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Comparison
4.1.1 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Comparison
4.2.1 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Comparison
4.3.1 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Myasthenia Gravis Diagnostic Reagents and Equipment Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Myasthenia Gravis Diagnostic Reagents and Equipment in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Myasthenia Gravis Diagnostic Reagents and Equipment Production by Domestic Manufacturer, (2017-2022)
4.5 China Myasthenia Gravis Diagnostic Reagents and Equipment Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Myasthenia Gravis Diagnostic Reagents and Equipment in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Myasthenia Gravis Diagnostic Reagents and Equipment Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Myasthenia Gravis Diagnostic Reagents and Equipment in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Detection reagent
5.2.2 EMG equipment
5.3 Market Segment by Type
5.3.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Type (2017-2028)
5.3.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Type (2017-2028)
5.3.3 World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Specialist Outpatient Clinic
6.2.3 Research Institutions
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Application (2017-2028)
6.3.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Application (2017-2028)
6.3.3 World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Argenx SE
7.1.1 Argenx SE Details
7.1.2 Argenx SE Major Business
7.1.3 Argenx SE Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.1.4 Argenx SE Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Argenx SE Recent Developments/Updates
7.1.6 Argenx SE Competitive Strengths & Weaknesses
7.2 American Regent
7.2.1 American Regent Details
7.2.2 American Regent Major Business
7.2.3 American Regent Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.2.4 American Regent Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 American Regent Recent Developments/Updates
7.2.6 American Regent Competitive Strengths & Weaknesses
7.3 Abcam
7.3.1 Abcam Details
7.3.2 Abcam Major Business
7.3.3 Abcam Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.3.4 Abcam Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Abcam Recent Developments/Updates
7.3.6 Abcam Competitive Strengths & Weaknesses
7.4 Sigma-Aldrich
7.4.1 Sigma-Aldrich Details
7.4.2 Sigma-Aldrich Major Business
7.4.3 Sigma-Aldrich Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.4.4 Sigma-Aldrich Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sigma-Aldrich Recent Developments/Updates
7.4.6 Sigma-Aldrich Competitive Strengths & Weaknesses
7.5 BioAssay Systems
7.5.1 BioAssay Systems Details
7.5.2 BioAssay Systems Major Business
7.5.3 BioAssay Systems Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.5.4 BioAssay Systems Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 BioAssay Systems Recent Developments/Updates
7.5.6 BioAssay Systems Competitive Strengths & Weaknesses
7.6 Attogene
7.6.1 Attogene Details
7.6.2 Attogene Major Business
7.6.3 Attogene Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.6.4 Attogene Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Attogene Recent Developments/Updates
7.6.6 Attogene Competitive Strengths & Weaknesses
7.7 Cambridge Bioscience
7.7.1 Cambridge Bioscience Details
7.7.2 Cambridge Bioscience Major Business
7.7.3 Cambridge Bioscience Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.7.4 Cambridge Bioscience Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Cambridge Bioscience Recent Developments/Updates
7.7.6 Cambridge Bioscience Competitive Strengths & Weaknesses
7.8 Invitrogen
7.8.1 Invitrogen Details
7.8.2 Invitrogen Major Business
7.8.3 Invitrogen Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.8.4 Invitrogen Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Invitrogen Recent Developments/Updates
7.8.6 Invitrogen Competitive Strengths & Weaknesses
7.9 Assay Genie
7.9.1 Assay Genie Details
7.9.2 Assay Genie Major Business
7.9.3 Assay Genie Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.9.4 Assay Genie Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Assay Genie Recent Developments/Updates
7.9.6 Assay Genie Competitive Strengths & Weaknesses
7.10 Neuro Medical Equipment, Inc.
7.10.1 Neuro Medical Equipment, Inc. Details
7.10.2 Neuro Medical Equipment, Inc. Major Business
7.10.3 Neuro Medical Equipment, Inc. Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.10.4 Neuro Medical Equipment, Inc. Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Neuro Medical Equipment, Inc. Recent Developments/Updates
7.10.6 Neuro Medical Equipment, Inc. Competitive Strengths & Weaknesses
7.11 Medtronic
7.11.1 Medtronic Details
7.11.2 Medtronic Major Business
7.11.3 Medtronic Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.11.4 Medtronic Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Medtronic Recent Developments/Updates
7.11.6 Medtronic Competitive Strengths & Weaknesses
7.12 Nihon Kohden
7.12.1 Nihon Kohden Details
7.12.2 Nihon Kohden Major Business
7.12.3 Nihon Kohden Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.12.4 Nihon Kohden Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Nihon Kohden Recent Developments/Updates
7.12.6 Nihon Kohden Competitive Strengths & Weaknesses
7.13 Natus Medical
7.13.1 Natus Medical Details
7.13.2 Natus Medical Major Business
7.13.3 Natus Medical Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.13.4 Natus Medical Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Natus Medical Recent Developments/Updates
7.13.6 Natus Medical Competitive Strengths & Weaknesses
7.14 Compumedics
7.14.1 Compumedics Details
7.14.2 Compumedics Major Business
7.14.3 Compumedics Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.14.4 Compumedics Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Compumedics Recent Developments/Updates
7.14.6 Compumedics Competitive Strengths & Weaknesses
7.15 Philips Healthcare
7.15.1 Philips Healthcare Details
7.15.2 Philips Healthcare Major Business
7.15.3 Philips Healthcare Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.15.4 Philips Healthcare Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Philips Healthcare Recent Developments/Updates
7.15.6 Philips Healthcare Competitive Strengths & Weaknesses
7.16 Micromed S.p.A.
7.16.1 Micromed S.p.A. Details
7.16.2 Micromed S.p.A. Major Business
7.16.3 Micromed S.p.A. Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.16.4 Micromed S.p.A. Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Micromed S.p.A. Recent Developments/Updates
7.16.6 Micromed S.p.A. Competitive Strengths & Weaknesses
7.17 Wuhan Huamei Biological Engineering Co., Ltd.
7.17.1 Wuhan Huamei Biological Engineering Co., Ltd. Details
7.17.2 Wuhan Huamei Biological Engineering Co., Ltd. Major Business
7.17.3 Wuhan Huamei Biological Engineering Co., Ltd. Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.17.4 Wuhan Huamei Biological Engineering Co., Ltd. Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Wuhan Huamei Biological Engineering Co., Ltd. Recent Developments/Updates
7.17.6 Wuhan Huamei Biological Engineering Co., Ltd. Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Myasthenia Gravis Diagnostic Reagents and Equipment and Key Manufacturers
8.2 Myasthenia Gravis Diagnostic Reagents and Equipment Manufacturing Costs
8.3 Myasthenia Gravis Diagnostic Reagents and Equipment Production Process
8.4 Myasthenia Gravis Diagnostic Reagents and Equipment Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Myasthenia Gravis Diagnostic Reagents and Equipment Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Myasthenia Gravis Diagnostic Reagents and Equipment Typical Distributors
9.3 Myasthenia Gravis Diagnostic Reagents and Equipment Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Myasthenia Gravis Diagnostic Reagents and Equipment Introduction
1.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Supply & Forecast
1.2.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value (2017 & 2021 & 2028)
1.2.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028)
1.2.3 World Myasthenia Gravis Diagnostic Reagents and Equipment Pricing Trends (2017-2028)
1.3 World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Region
1.3.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Region (2017-2028)
1.3.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Region (2017-2028)
1.3.3 World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Region (2017-2028)
1.3.4 North America Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028)
1.3.5 Europe Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028)
1.3.6 China Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028)
1.3.7 Japan Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Myasthenia Gravis Diagnostic Reagents and Equipment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Myasthenia Gravis Diagnostic Reagents and Equipment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Demand (2017-2028)
2.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption by Region
2.2.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption by Region (2017-2022)
2.2.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Forecast by Region (2023-2028)
2.3 United States Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
2.4 China Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
2.5 Europe Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
2.6 Japan Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
2.7 South Korea Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
2.8 ASEAN Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
2.9 India Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028)
3 WORLD MYASTHENIA GRAVIS DIAGNOSTIC REAGENTS AND EQUIPMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Manufacturer (2017-2022)
3.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Manufacturer (2017-2022)
3.3 World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Manufacturer (2017-2022)
3.4 Myasthenia Gravis Diagnostic Reagents and Equipment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Myasthenia Gravis Diagnostic Reagents and Equipment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Myasthenia Gravis Diagnostic Reagents and Equipment in 2021
3.5.3 Global Concentration Ratios (CR8) for Myasthenia Gravis Diagnostic Reagents and Equipment in 2021
3.6 Myasthenia Gravis Diagnostic Reagents and Equipment Market: Overall Company Footprint Analysis
3.6.1 Myasthenia Gravis Diagnostic Reagents and Equipment Market: Region Footprint
3.6.2 Myasthenia Gravis Diagnostic Reagents and Equipment Market: Company Product Type Footprint
3.6.3 Myasthenia Gravis Diagnostic Reagents and Equipment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Comparison
4.1.1 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Comparison
4.2.1 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Comparison
4.3.1 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Myasthenia Gravis Diagnostic Reagents and Equipment Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Myasthenia Gravis Diagnostic Reagents and Equipment in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Myasthenia Gravis Diagnostic Reagents and Equipment Production by Domestic Manufacturer, (2017-2022)
4.5 China Myasthenia Gravis Diagnostic Reagents and Equipment Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Myasthenia Gravis Diagnostic Reagents and Equipment in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Myasthenia Gravis Diagnostic Reagents and Equipment Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Myasthenia Gravis Diagnostic Reagents and Equipment in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Detection reagent
5.2.2 EMG equipment
5.3 Market Segment by Type
5.3.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Type (2017-2028)
5.3.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Type (2017-2028)
5.3.3 World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Specialist Outpatient Clinic
6.2.3 Research Institutions
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Application (2017-2028)
6.3.2 World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Application (2017-2028)
6.3.3 World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Argenx SE
7.1.1 Argenx SE Details
7.1.2 Argenx SE Major Business
7.1.3 Argenx SE Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.1.4 Argenx SE Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Argenx SE Recent Developments/Updates
7.1.6 Argenx SE Competitive Strengths & Weaknesses
7.2 American Regent
7.2.1 American Regent Details
7.2.2 American Regent Major Business
7.2.3 American Regent Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.2.4 American Regent Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 American Regent Recent Developments/Updates
7.2.6 American Regent Competitive Strengths & Weaknesses
7.3 Abcam
7.3.1 Abcam Details
7.3.2 Abcam Major Business
7.3.3 Abcam Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.3.4 Abcam Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Abcam Recent Developments/Updates
7.3.6 Abcam Competitive Strengths & Weaknesses
7.4 Sigma-Aldrich
7.4.1 Sigma-Aldrich Details
7.4.2 Sigma-Aldrich Major Business
7.4.3 Sigma-Aldrich Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.4.4 Sigma-Aldrich Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sigma-Aldrich Recent Developments/Updates
7.4.6 Sigma-Aldrich Competitive Strengths & Weaknesses
7.5 BioAssay Systems
7.5.1 BioAssay Systems Details
7.5.2 BioAssay Systems Major Business
7.5.3 BioAssay Systems Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.5.4 BioAssay Systems Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 BioAssay Systems Recent Developments/Updates
7.5.6 BioAssay Systems Competitive Strengths & Weaknesses
7.6 Attogene
7.6.1 Attogene Details
7.6.2 Attogene Major Business
7.6.3 Attogene Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.6.4 Attogene Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Attogene Recent Developments/Updates
7.6.6 Attogene Competitive Strengths & Weaknesses
7.7 Cambridge Bioscience
7.7.1 Cambridge Bioscience Details
7.7.2 Cambridge Bioscience Major Business
7.7.3 Cambridge Bioscience Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.7.4 Cambridge Bioscience Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Cambridge Bioscience Recent Developments/Updates
7.7.6 Cambridge Bioscience Competitive Strengths & Weaknesses
7.8 Invitrogen
7.8.1 Invitrogen Details
7.8.2 Invitrogen Major Business
7.8.3 Invitrogen Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.8.4 Invitrogen Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Invitrogen Recent Developments/Updates
7.8.6 Invitrogen Competitive Strengths & Weaknesses
7.9 Assay Genie
7.9.1 Assay Genie Details
7.9.2 Assay Genie Major Business
7.9.3 Assay Genie Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.9.4 Assay Genie Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Assay Genie Recent Developments/Updates
7.9.6 Assay Genie Competitive Strengths & Weaknesses
7.10 Neuro Medical Equipment, Inc.
7.10.1 Neuro Medical Equipment, Inc. Details
7.10.2 Neuro Medical Equipment, Inc. Major Business
7.10.3 Neuro Medical Equipment, Inc. Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.10.4 Neuro Medical Equipment, Inc. Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Neuro Medical Equipment, Inc. Recent Developments/Updates
7.10.6 Neuro Medical Equipment, Inc. Competitive Strengths & Weaknesses
7.11 Medtronic
7.11.1 Medtronic Details
7.11.2 Medtronic Major Business
7.11.3 Medtronic Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.11.4 Medtronic Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Medtronic Recent Developments/Updates
7.11.6 Medtronic Competitive Strengths & Weaknesses
7.12 Nihon Kohden
7.12.1 Nihon Kohden Details
7.12.2 Nihon Kohden Major Business
7.12.3 Nihon Kohden Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.12.4 Nihon Kohden Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Nihon Kohden Recent Developments/Updates
7.12.6 Nihon Kohden Competitive Strengths & Weaknesses
7.13 Natus Medical
7.13.1 Natus Medical Details
7.13.2 Natus Medical Major Business
7.13.3 Natus Medical Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.13.4 Natus Medical Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Natus Medical Recent Developments/Updates
7.13.6 Natus Medical Competitive Strengths & Weaknesses
7.14 Compumedics
7.14.1 Compumedics Details
7.14.2 Compumedics Major Business
7.14.3 Compumedics Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.14.4 Compumedics Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Compumedics Recent Developments/Updates
7.14.6 Compumedics Competitive Strengths & Weaknesses
7.15 Philips Healthcare
7.15.1 Philips Healthcare Details
7.15.2 Philips Healthcare Major Business
7.15.3 Philips Healthcare Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.15.4 Philips Healthcare Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Philips Healthcare Recent Developments/Updates
7.15.6 Philips Healthcare Competitive Strengths & Weaknesses
7.16 Micromed S.p.A.
7.16.1 Micromed S.p.A. Details
7.16.2 Micromed S.p.A. Major Business
7.16.3 Micromed S.p.A. Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.16.4 Micromed S.p.A. Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Micromed S.p.A. Recent Developments/Updates
7.16.6 Micromed S.p.A. Competitive Strengths & Weaknesses
7.17 Wuhan Huamei Biological Engineering Co., Ltd.
7.17.1 Wuhan Huamei Biological Engineering Co., Ltd. Details
7.17.2 Wuhan Huamei Biological Engineering Co., Ltd. Major Business
7.17.3 Wuhan Huamei Biological Engineering Co., Ltd. Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
7.17.4 Wuhan Huamei Biological Engineering Co., Ltd. Myasthenia Gravis Diagnostic Reagents and Equipment Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Wuhan Huamei Biological Engineering Co., Ltd. Recent Developments/Updates
7.17.6 Wuhan Huamei Biological Engineering Co., Ltd. Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Myasthenia Gravis Diagnostic Reagents and Equipment and Key Manufacturers
8.2 Myasthenia Gravis Diagnostic Reagents and Equipment Manufacturing Costs
8.3 Myasthenia Gravis Diagnostic Reagents and Equipment Production Process
8.4 Myasthenia Gravis Diagnostic Reagents and Equipment Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Myasthenia Gravis Diagnostic Reagents and Equipment Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Myasthenia Gravis Diagnostic Reagents and Equipment Typical Distributors
9.3 Myasthenia Gravis Diagnostic Reagents and Equipment Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Region (2017-2022) & (USD Million)
Table 3. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Region (2023-2028) & (USD Million)
Table 4. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Region (2017-2022)
Table 5. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Region (2023-2028)
Table 6. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Region (2017-2022) & (K Units)
Table 7. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Region (2023-2028) & (K Units)
Table 8. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Region (2017-2022)
Table 9. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Region (2023-2028)
Table 10. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Myasthenia Gravis Diagnostic Reagents and Equipment Major Market Trends
Table 13. World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption by Region (2017-2022) & (K Units)
Table 15. World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Myasthenia Gravis Diagnostic Reagents and Equipment Producers in 2021
Table 18. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Myasthenia Gravis Diagnostic Reagents and Equipment Producers in 2021
Table 20. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Myasthenia Gravis Diagnostic Reagents and Equipment Company Evaluation Quadrant
Table 22. World Myasthenia Gravis Diagnostic Reagents and Equipment Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Myasthenia Gravis Diagnostic Reagents and Equipment Production Site of Key Manufacturer
Table 24. Myasthenia Gravis Diagnostic Reagents and Equipment Market: Company Product Type Footprint
Table 25. Myasthenia Gravis Diagnostic Reagents and Equipment Market: Company Product Application Footprint
Table 26. Myasthenia Gravis Diagnostic Reagents and Equipment Competitive Factors
Table 27. Myasthenia Gravis Diagnostic Reagents and Equipment New Entrant and Capacity Expansion Plans
Table 28. Myasthenia Gravis Diagnostic Reagents and Equipment Mergers & Acquisitions Activity
Table 29. United States VS China Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Myasthenia Gravis Diagnostic Reagents and Equipment Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Myasthenia Gravis Diagnostic Reagents and Equipment in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Myasthenia Gravis Diagnostic Reagents and Equipment Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Myasthenia Gravis Diagnostic Reagents and Equipment in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Myasthenia Gravis Diagnostic Reagents and Equipment Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Myasthenia Gravis Diagnostic Reagents and Equipment in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Type (2017-2022) & (K Units)
Table 49. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Type (2023-2028) & (K Units)
Table 50. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Type (2017-2022) & (USD Million)
Table 51. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Type (2023-2028) & (USD Million)
Table 52. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Application (2017-2022) & (K Units)
Table 56. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Application (2023-2028) & (K Units)
Table 57. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Application (2017-2022) & (USD Million)
Table 58. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Application (2023-2028) & (USD Million)
Table 59. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Argenx SE Basic Information, Manufacturing Base and Competitors
Table 62. Argenx SE Major Business
Table 63. Argenx SE Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 64. Argenx SE Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Argenx SE Recent Developments/Updates
Table 66. Argenx SE Competitive Strengths & Weaknesses
Table 67. American Regent Basic Information, Manufacturing Base and Competitors
Table 68. American Regent Major Business
Table 69. American Regent Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 70. American Regent Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. American Regent Recent Developments/Updates
Table 72. American Regent Competitive Strengths & Weaknesses
Table 73. Abcam Basic Information, Manufacturing Base and Competitors
Table 74. Abcam Major Business
Table 75. Abcam Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 76. Abcam Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Abcam Recent Developments/Updates
Table 78. Abcam Competitive Strengths & Weaknesses
Table 79. Sigma-Aldrich Basic Information, Manufacturing Base and Competitors
Table 80. Sigma-Aldrich Major Business
Table 81. Sigma-Aldrich Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 82. Sigma-Aldrich Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sigma-Aldrich Recent Developments/Updates
Table 84. Sigma-Aldrich Competitive Strengths & Weaknesses
Table 85. BioAssay Systems Basic Information, Manufacturing Base and Competitors
Table 86. BioAssay Systems Major Business
Table 87. BioAssay Systems Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 88. BioAssay Systems Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. BioAssay Systems Recent Developments/Updates
Table 90. BioAssay Systems Competitive Strengths & Weaknesses
Table 91. Attogene Basic Information, Manufacturing Base and Competitors
Table 92. Attogene Major Business
Table 93. Attogene Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 94. Attogene Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Attogene Recent Developments/Updates
Table 96. Attogene Competitive Strengths & Weaknesses
Table 97. Cambridge Bioscience Basic Information, Manufacturing Base and Competitors
Table 98. Cambridge Bioscience Major Business
Table 99. Cambridge Bioscience Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 100. Cambridge Bioscience Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Cambridge Bioscience Recent Developments/Updates
Table 102. Cambridge Bioscience Competitive Strengths & Weaknesses
Table 103. Invitrogen Basic Information, Manufacturing Base and Competitors
Table 104. Invitrogen Major Business
Table 105. Invitrogen Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 106. Invitrogen Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Invitrogen Recent Developments/Updates
Table 108. Invitrogen Competitive Strengths & Weaknesses
Table 109. Assay Genie Basic Information, Manufacturing Base and Competitors
Table 110. Assay Genie Major Business
Table 111. Assay Genie Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 112. Assay Genie Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Assay Genie Recent Developments/Updates
Table 114. Assay Genie Competitive Strengths & Weaknesses
Table 115. Neuro Medical Equipment, Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Neuro Medical Equipment, Inc. Major Business
Table 117. Neuro Medical Equipment, Inc. Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 118. Neuro Medical Equipment, Inc. Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Neuro Medical Equipment, Inc. Recent Developments/Updates
Table 120. Neuro Medical Equipment, Inc. Competitive Strengths & Weaknesses
Table 121. Medtronic Basic Information, Manufacturing Base and Competitors
Table 122. Medtronic Major Business
Table 123. Medtronic Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 124. Medtronic Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Medtronic Recent Developments/Updates
Table 126. Medtronic Competitive Strengths & Weaknesses
Table 127. Nihon Kohden Basic Information, Manufacturing Base and Competitors
Table 128. Nihon Kohden Major Business
Table 129. Nihon Kohden Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 130. Nihon Kohden Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Nihon Kohden Recent Developments/Updates
Table 132. Nihon Kohden Competitive Strengths & Weaknesses
Table 133. Natus Medical Basic Information, Manufacturing Base and Competitors
Table 134. Natus Medical Major Business
Table 135. Natus Medical Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 136. Natus Medical Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Natus Medical Recent Developments/Updates
Table 138. Natus Medical Competitive Strengths & Weaknesses
Table 139. Compumedics Basic Information, Manufacturing Base and Competitors
Table 140. Compumedics Major Business
Table 141. Compumedics Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 142. Compumedics Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Compumedics Recent Developments/Updates
Table 144. Compumedics Competitive Strengths & Weaknesses
Table 145. Philips Healthcare Basic Information, Manufacturing Base and Competitors
Table 146. Philips Healthcare Major Business
Table 147. Philips Healthcare Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 148. Philips Healthcare Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Philips Healthcare Recent Developments/Updates
Table 150. Philips Healthcare Competitive Strengths & Weaknesses
Table 151. Micromed S.p.A. Basic Information, Manufacturing Base and Competitors
Table 152. Micromed S.p.A. Major Business
Table 153. Micromed S.p.A. Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 154. Micromed S.p.A. Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Micromed S.p.A. Recent Developments/Updates
Table 156. Wuhan Huamei Biological Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 157. Wuhan Huamei Biological Engineering Co., Ltd. Major Business
Table 158. Wuhan Huamei Biological Engineering Co., Ltd. Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 159. Wuhan Huamei Biological Engineering Co., Ltd. Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 160. Myasthenia Gravis Diagnostic Reagents and Equipment Raw Material
Table 161. Key Manufacturers of Myasthenia Gravis Diagnostic Reagents and Equipment Raw Materials
Table 162. Myasthenia Gravis Diagnostic Reagents and Equipment Typical Distributors
Table 163. Myasthenia Gravis Diagnostic Reagents and Equipment Typical Customers
List of Figure
Figure 1. Myasthenia Gravis Diagnostic Reagents and Equipment Picture
Figure 2. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028) & (K Units)
Figure 5. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price (2017-2028) & (US$/Unit)
Figure 6. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Region (2017-2028)
Figure 7. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Region (2017-2028)
Figure 8. North America Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028) & (K Units)
Figure 9. Europe Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028) & (K Units)
Figure 10. China Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028) & (K Units)
Figure 11. Japan Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028) & (K Units)
Figure 12. Myasthenia Gravis Diagnostic Reagents and Equipment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Myasthenia Gravis Diagnostic Reagents and Equipment Demand (2017-2028) & (K Units)
Figure 15. World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Market Share by Region (2017-2028)
Figure 16. United States Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 17. China Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 18. Europe Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 19. Japan Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 20. South Korea Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 22. India Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Myasthenia Gravis Diagnostic Reagents and Equipment by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Myasthenia Gravis Diagnostic Reagents and Equipment Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Myasthenia Gravis Diagnostic Reagents and Equipment Markets in 2021
Figure 26. United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Myasthenia Gravis Diagnostic Reagents and Equipment in United States
Figure 30. Key Producers and Market Share of Myasthenia Gravis Diagnostic Reagents and Equipment in China
Figure 31. Key Producers and Market Share of Myasthenia Gravis Diagnostic Reagents and Equipment in Rest of World
Figure 32. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Type in 2021
Figure 34. Detection reagent
Figure 35. EMG equipment
Figure 36. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Type (2017-2028)
Figure 37. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Type (2017-2028)
Figure 38. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Specialist Outpatient Clinic
Figure 43. Research Institutions
Figure 44. Other
Figure 45. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Application (2017-2028)
Figure 46. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Application (2017-2028)
Figure 47. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Myasthenia Gravis Diagnostic Reagents and Equipment in 2021
Figure 49. Manufacturing Process Analysis of Myasthenia Gravis Diagnostic Reagents and Equipment
Figure 50. Myasthenia Gravis Diagnostic Reagents and Equipment Industrial Chain
Figure 51. Distribution Channel Breakdown for Myasthenia Gravis Diagnostic Reagents and Equipment Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
Table 1. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Region (2017-2022) & (USD Million)
Table 3. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Region (2023-2028) & (USD Million)
Table 4. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Region (2017-2022)
Table 5. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Region (2023-2028)
Table 6. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Region (2017-2022) & (K Units)
Table 7. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Region (2023-2028) & (K Units)
Table 8. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Region (2017-2022)
Table 9. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Region (2023-2028)
Table 10. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Myasthenia Gravis Diagnostic Reagents and Equipment Major Market Trends
Table 13. World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption by Region (2017-2022) & (K Units)
Table 15. World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Myasthenia Gravis Diagnostic Reagents and Equipment Producers in 2021
Table 18. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Myasthenia Gravis Diagnostic Reagents and Equipment Producers in 2021
Table 20. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Myasthenia Gravis Diagnostic Reagents and Equipment Company Evaluation Quadrant
Table 22. World Myasthenia Gravis Diagnostic Reagents and Equipment Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Myasthenia Gravis Diagnostic Reagents and Equipment Production Site of Key Manufacturer
Table 24. Myasthenia Gravis Diagnostic Reagents and Equipment Market: Company Product Type Footprint
Table 25. Myasthenia Gravis Diagnostic Reagents and Equipment Market: Company Product Application Footprint
Table 26. Myasthenia Gravis Diagnostic Reagents and Equipment Competitive Factors
Table 27. Myasthenia Gravis Diagnostic Reagents and Equipment New Entrant and Capacity Expansion Plans
Table 28. Myasthenia Gravis Diagnostic Reagents and Equipment Mergers & Acquisitions Activity
Table 29. United States VS China Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Myasthenia Gravis Diagnostic Reagents and Equipment Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Myasthenia Gravis Diagnostic Reagents and Equipment in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Myasthenia Gravis Diagnostic Reagents and Equipment Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Myasthenia Gravis Diagnostic Reagents and Equipment in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Myasthenia Gravis Diagnostic Reagents and Equipment Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Myasthenia Gravis Diagnostic Reagents and Equipment in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Type (2017-2022) & (K Units)
Table 49. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Type (2023-2028) & (K Units)
Table 50. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Type (2017-2022) & (USD Million)
Table 51. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Type (2023-2028) & (USD Million)
Table 52. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Application (2017-2022) & (K Units)
Table 56. World Myasthenia Gravis Diagnostic Reagents and Equipment Production by Application (2023-2028) & (K Units)
Table 57. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Application (2017-2022) & (USD Million)
Table 58. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Application (2023-2028) & (USD Million)
Table 59. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Argenx SE Basic Information, Manufacturing Base and Competitors
Table 62. Argenx SE Major Business
Table 63. Argenx SE Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 64. Argenx SE Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Argenx SE Recent Developments/Updates
Table 66. Argenx SE Competitive Strengths & Weaknesses
Table 67. American Regent Basic Information, Manufacturing Base and Competitors
Table 68. American Regent Major Business
Table 69. American Regent Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 70. American Regent Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. American Regent Recent Developments/Updates
Table 72. American Regent Competitive Strengths & Weaknesses
Table 73. Abcam Basic Information, Manufacturing Base and Competitors
Table 74. Abcam Major Business
Table 75. Abcam Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 76. Abcam Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Abcam Recent Developments/Updates
Table 78. Abcam Competitive Strengths & Weaknesses
Table 79. Sigma-Aldrich Basic Information, Manufacturing Base and Competitors
Table 80. Sigma-Aldrich Major Business
Table 81. Sigma-Aldrich Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 82. Sigma-Aldrich Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sigma-Aldrich Recent Developments/Updates
Table 84. Sigma-Aldrich Competitive Strengths & Weaknesses
Table 85. BioAssay Systems Basic Information, Manufacturing Base and Competitors
Table 86. BioAssay Systems Major Business
Table 87. BioAssay Systems Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 88. BioAssay Systems Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. BioAssay Systems Recent Developments/Updates
Table 90. BioAssay Systems Competitive Strengths & Weaknesses
Table 91. Attogene Basic Information, Manufacturing Base and Competitors
Table 92. Attogene Major Business
Table 93. Attogene Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 94. Attogene Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Attogene Recent Developments/Updates
Table 96. Attogene Competitive Strengths & Weaknesses
Table 97. Cambridge Bioscience Basic Information, Manufacturing Base and Competitors
Table 98. Cambridge Bioscience Major Business
Table 99. Cambridge Bioscience Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 100. Cambridge Bioscience Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Cambridge Bioscience Recent Developments/Updates
Table 102. Cambridge Bioscience Competitive Strengths & Weaknesses
Table 103. Invitrogen Basic Information, Manufacturing Base and Competitors
Table 104. Invitrogen Major Business
Table 105. Invitrogen Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 106. Invitrogen Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Invitrogen Recent Developments/Updates
Table 108. Invitrogen Competitive Strengths & Weaknesses
Table 109. Assay Genie Basic Information, Manufacturing Base and Competitors
Table 110. Assay Genie Major Business
Table 111. Assay Genie Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 112. Assay Genie Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Assay Genie Recent Developments/Updates
Table 114. Assay Genie Competitive Strengths & Weaknesses
Table 115. Neuro Medical Equipment, Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Neuro Medical Equipment, Inc. Major Business
Table 117. Neuro Medical Equipment, Inc. Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 118. Neuro Medical Equipment, Inc. Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Neuro Medical Equipment, Inc. Recent Developments/Updates
Table 120. Neuro Medical Equipment, Inc. Competitive Strengths & Weaknesses
Table 121. Medtronic Basic Information, Manufacturing Base and Competitors
Table 122. Medtronic Major Business
Table 123. Medtronic Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 124. Medtronic Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Medtronic Recent Developments/Updates
Table 126. Medtronic Competitive Strengths & Weaknesses
Table 127. Nihon Kohden Basic Information, Manufacturing Base and Competitors
Table 128. Nihon Kohden Major Business
Table 129. Nihon Kohden Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 130. Nihon Kohden Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Nihon Kohden Recent Developments/Updates
Table 132. Nihon Kohden Competitive Strengths & Weaknesses
Table 133. Natus Medical Basic Information, Manufacturing Base and Competitors
Table 134. Natus Medical Major Business
Table 135. Natus Medical Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 136. Natus Medical Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Natus Medical Recent Developments/Updates
Table 138. Natus Medical Competitive Strengths & Weaknesses
Table 139. Compumedics Basic Information, Manufacturing Base and Competitors
Table 140. Compumedics Major Business
Table 141. Compumedics Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 142. Compumedics Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Compumedics Recent Developments/Updates
Table 144. Compumedics Competitive Strengths & Weaknesses
Table 145. Philips Healthcare Basic Information, Manufacturing Base and Competitors
Table 146. Philips Healthcare Major Business
Table 147. Philips Healthcare Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 148. Philips Healthcare Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Philips Healthcare Recent Developments/Updates
Table 150. Philips Healthcare Competitive Strengths & Weaknesses
Table 151. Micromed S.p.A. Basic Information, Manufacturing Base and Competitors
Table 152. Micromed S.p.A. Major Business
Table 153. Micromed S.p.A. Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 154. Micromed S.p.A. Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Micromed S.p.A. Recent Developments/Updates
Table 156. Wuhan Huamei Biological Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 157. Wuhan Huamei Biological Engineering Co., Ltd. Major Business
Table 158. Wuhan Huamei Biological Engineering Co., Ltd. Myasthenia Gravis Diagnostic Reagents and Equipment Product and Services
Table 159. Wuhan Huamei Biological Engineering Co., Ltd. Myasthenia Gravis Diagnostic Reagents and Equipment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 160. Myasthenia Gravis Diagnostic Reagents and Equipment Raw Material
Table 161. Key Manufacturers of Myasthenia Gravis Diagnostic Reagents and Equipment Raw Materials
Table 162. Myasthenia Gravis Diagnostic Reagents and Equipment Typical Distributors
Table 163. Myasthenia Gravis Diagnostic Reagents and Equipment Typical Customers
List of Figure
Figure 1. Myasthenia Gravis Diagnostic Reagents and Equipment Picture
Figure 2. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028) & (K Units)
Figure 5. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price (2017-2028) & (US$/Unit)
Figure 6. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Region (2017-2028)
Figure 7. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Region (2017-2028)
Figure 8. North America Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028) & (K Units)
Figure 9. Europe Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028) & (K Units)
Figure 10. China Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028) & (K Units)
Figure 11. Japan Myasthenia Gravis Diagnostic Reagents and Equipment Production (2017-2028) & (K Units)
Figure 12. Myasthenia Gravis Diagnostic Reagents and Equipment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Myasthenia Gravis Diagnostic Reagents and Equipment Demand (2017-2028) & (K Units)
Figure 15. World Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Market Share by Region (2017-2028)
Figure 16. United States Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 17. China Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 18. Europe Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 19. Japan Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 20. South Korea Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 22. India Myasthenia Gravis Diagnostic Reagents and Equipment Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Myasthenia Gravis Diagnostic Reagents and Equipment by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Myasthenia Gravis Diagnostic Reagents and Equipment Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Myasthenia Gravis Diagnostic Reagents and Equipment Markets in 2021
Figure 26. United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Myasthenia Gravis Diagnostic Reagents and Equipment Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Myasthenia Gravis Diagnostic Reagents and Equipment in United States
Figure 30. Key Producers and Market Share of Myasthenia Gravis Diagnostic Reagents and Equipment in China
Figure 31. Key Producers and Market Share of Myasthenia Gravis Diagnostic Reagents and Equipment in Rest of World
Figure 32. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Type in 2021
Figure 34. Detection reagent
Figure 35. EMG equipment
Figure 36. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Type (2017-2028)
Figure 37. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Type (2017-2028)
Figure 38. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Specialist Outpatient Clinic
Figure 43. Research Institutions
Figure 44. Other
Figure 45. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Market Share by Application (2017-2028)
Figure 46. World Myasthenia Gravis Diagnostic Reagents and Equipment Production Value Market Share by Application (2017-2028)
Figure 47. World Myasthenia Gravis Diagnostic Reagents and Equipment Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Myasthenia Gravis Diagnostic Reagents and Equipment in 2021
Figure 49. Manufacturing Process Analysis of Myasthenia Gravis Diagnostic Reagents and Equipment
Figure 50. Myasthenia Gravis Diagnostic Reagents and Equipment Industrial Chain
Figure 51. Distribution Channel Breakdown for Myasthenia Gravis Diagnostic Reagents and Equipment Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
